Incruse Ellipta Inhaler 62.5mcg and/or Equivalents
Incruse Ellipta Inhaler 62.5mcg
 
Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom
Manufactured by: Glaxosmithkline
This product is offered for sale by a Licensed Pharmacy located in the United Kingdom
From $2.71 USD/dose
CAN NOT BE SPLIT Must be taken in existing form.
No Generic Alternative Available
No generic alternative is available for this drug.
More Brand Products
| Product | Lowest Unit Price | 
|---|---|
| Incruse Ellipta Inhaler 62.5mcg Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom — Manufactured by: Glaxosmithkline | $2.71 USD/dose | 
| Incruse Ellipta Inhaler 62.5mcg Marketed as Incruse Ellipta Inhaler 62.5mcg in New Zealand — Manufactured by: Glaxosmithkline | $3.15 USD/dose | 
| Incruse Ellipta Inhaler 62.5mcg Marketed as Incruse Ellipta Inhaler 62.5mcg in Australia — Manufactured by: Glaxosmithkline | $3.12 USD/dose | 
| Incruse Ellipta Inhaler 62.5mcg Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom — Manufactured by: Glaxosmithkline | $2.74 USD/dose | 
| Incruse Ellipta Inhaler 62.5mcg Marketed as Incruse Ellipta Inhaler 55mcg in Canada — Manufactured by: Glaxosmithkline | $2.81 USD/dose | 
No generic alternatives are available for this drug.
 
 
 
